Literature DB >> 2713842

Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats.

C Grunfeld1, H Wilking, R Neese, L A Gavin, A H Moser, R Gulli, M K Serio, K R Feingold.   

Abstract

The administration of a single injection of tumor necrosis factor (TNF) produces a variety of acute and sustained biological effects, including hyperlipidemia, stimulation of hepatic lipogenesis, decreases in adipose tissue lipoprotein lipase activity, and anorexia with weight loss. Chronic administration of a fixed dose of TNF produces tachyphylaxis to the anorectic/cachectic effects of TNF. We now report that the hyperlipidemic effect of TNF persists during chronic TNF administration in the absence of any cachectic effect of TNF. Sprague-Dawley rats injected with TNF (250 micrograms/kg) show a significant decrease in weight over the next 24 h which can be accounted for by decreases in food and water intake accompanied by an increase in urine output. With subsequent daily injections of TNF, treated rats begin eating and rapidly regain weight. Hypertriglyceridemia persists for up to 10 days of daily injections of TNF. After three daily injections of TNF, no decreases were seen in lipoprotein lipase activity in a wide variety of tissues. De novo hepatic lipogenesis remained increased in TNF-treated animals after four daily injections, but by the fifth day hepatic lipogenesis returned to normal. After 5 days of TNF treatment the acute incorporation of labeled glycerol into serum triglycerides remained elevated. These data indicate that hyperlipidemia persists during multiple daily injections of TNF and that TNF induced hypertriglyceridemia is not inevitably linked to the syndrome of cachexia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2713842

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  The modulation of plasma lipids and lipoproteins during bone marrow transplantation is unrelated to exogenously administered recombinant human granulocyte-monocyte colony-stimulating factor (rHu GM-CSF).

Authors:  E J Dann; Y Friedlander; E Leitersdorf; A Nagler
Journal:  Med Oncol       Date:  1996-06       Impact factor: 3.064

2.  Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters.

Authors:  C Grunfeld; C Zhao; J Fuller; A Pollack; A Moser; J Friedman; K R Feingold
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

3.  Systemic administration of lipopolysaccharide increases plasma leptin levels: blockade by soluble interleukin-1 receptor.

Authors:  J Francis; P S MohanKumar; S M MohanKumar; S K Quadri
Journal:  Endocrine       Date:  1999-06       Impact factor: 3.633

4.  Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation.

Authors:  R Roubenoff; R A Roubenoff; J G Cannon; J J Kehayias; H Zhuang; B Dawson-Hughes; C A Dinarello; I H Rosenberg
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

5.  A phase II combination trial with recombinant human tumor necrosis factor and gamma interferon in patients with colorectal cancer.

Authors:  W Fiedler; W Zeller; C J Peimann; H J Weh; D K Hossfeld
Journal:  Klin Wochenschr       Date:  1991-04-04

6.  The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.

Authors:  P A Kern; M Saghizadeh; J M Ong; R J Bosch; R Deem; R B Simsolo
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

Review 7.  PI3K signaling: A molecular pathway associated with acute hypophagic response during inflammatory challenges.

Authors:  Beatriz C Borges; Carol F Elias; Lucila L K Elias
Journal:  Mol Cell Endocrinol       Date:  2016-07-05       Impact factor: 4.102

Review 8.  Cancer cachexia.

Authors:  M J Tisdale
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

9.  Effect of megestrol acetate on weight loss induced by tumour necrosis factor alpha and a cachexia-inducing tumour (MAC16) in NMRI mice.

Authors:  S A Beck; M J Tisdale
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

10.  Humoral mediation for cachexia in tumour-bearing rats.

Authors:  L Tessitore; P Costelli; F M Baccino
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.